Published in Mol Biosyst on July 08, 2009
Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes. Chem Res Toxicol (2011) 0.80
Cytosolic thioredoxin reductase 1 is required for correct disulfide formation in the ER. EMBO J (2017) 0.75
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions. J Med Chem (2016) 0.75
Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem (1962) 7.31
Refined structure of glutathione reductase at 1.54 A resolution. J Mol Biol (1987) 2.60
Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol (2007) 2.31
Marine natural products of fungal origin. Nat Prod Rep (2007) 2.18
Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucine. Anal Chem (1987) 2.10
New aspects of natural products in drug discovery. Trends Microbiol (2007) 2.06
Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol (2006) 1.99
Cordyceps fungi: natural products, pharmacological functions and developmental products. J Pharm Pharmacol (2009) 1.95
Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Anal Chem (1998) 1.90
On the reaction mechanism of yeast glutathione reductase. J Biol Chem (1965) 1.80
Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem Res Toxicol (2006) 1.69
The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61
Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Free Radic Biol Med (2005) 1.58
Anti-tumour compounds illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways. DNA Repair (Amst) (2002) 1.17
Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J Biol Chem (2001) 1.15
Structure of glutathione reductase from Escherichia coli at 1.86 A resolution: comparison with the enzyme from human erythrocytes. Protein Sci (1994) 1.12
A fluoro analogue of the menadione derivative 6-[2'-(3'-methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme. J Am Chem Soc (2006) 1.05
Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells. Clin Cancer Res (2004) 1.05
Complementary use of MALDI and ESI for the HPLC-MS/MS analysis of DNA-binding proteins. Anal Chem (2004) 1.05
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. Cancer Res (1997) 1.02
Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem (2008) 1.02
(Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties. J Nat Prod (1996) 1.01
Antibiotic substances from Basidiomycetes+. VII. Clitocybe illudens. Proc Natl Acad Sci U S A (1950) 0.99
Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF). Biochem Pharmacol (1999) 0.99
Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol (1997) 0.97
Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem (1981) 0.97
FUNGAL METABOLITES. THE STRUCTURES OF THE NOVEL SESQUITERPENOIDS ILLUDIN-S AND -M. J Am Chem Soc (1965) 0.96
Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicity. J Natl Cancer Inst (1990) 0.95
The thiol-based redox networks of pathogens: unexploited targets in the search for new drugs. Biofactors (2006) 0.94
Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent. J Am Chem Soc (2007) 0.92
Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels. Biochem Pharmacol (2003) 0.90
Investigating the role of stereochemistry in the activity of anticancer acylfulvenes: synthesis, reductase-mediated bioactivation, and cellular toxicity. J Med Chem (2006) 0.90
NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven. Clin Cancer Res (2004) 0.89
On the mechanism of toxicity of illudins: the role of glutathione. Chem Res Toxicol (1991) 0.89
Structure-activity relationships for the impact of selected isothiazol-3-one biocides on glutathione metabolism and glutathione reductase of the human liver cell line Hep G2. Toxicology (2008) 0.88
Acylfulvenes, a new class of potent antitumor agents. Experientia (1996) 0.87
Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin. Clin Cancer Res (2003) 0.87
Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function. Biochem Pharmacol (1997) 0.86
Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines. Cancer Chemother Pharmacol (1999) 0.84
The sequence of amino acid residues around the oxidation-reduction active disulfide in yeast glutathione reductase. J Biol Chem (1975) 0.82
Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units. Anticancer Drugs (1999) 0.82
Inhibition of yeast glutathione reductase by trehalose: possible implications in yeast survival and recovery from stress. Int J Biochem Cell Biol (2004) 0.81
Characterization of acylfulvene histiospecific toxicity in human tumor cell lines. Cancer Chemother Pharmacol (1998) 0.81
Predissociated dimers and molten globule monomers in the equilibrium unfolding of yeast glutathione reductase. Biophys J (2003) 0.81
Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents. Invest New Drugs (1996) 0.80
Metabolism of antitumor acylfulvene by rat liver cytosol. Biochem Pharmacol (1999) 0.80
Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors. Drug Metab Dispos (2006) 0.80
Metabolism of illudin S, a toxic principle of Lampteromyces japonicus, by rat liver. I. Isolation and identification of cyclopropane ring-cleavage metabolites. Xenobiotica (1990) 0.79
Metabolism of antitumor hydroxymethylacylfulvene by rat liver cytosol. Drug Metab Dispos (1999) 0.79
Michael-type addition of illudin S, a toxic substance from Lampteromyces japonicus, with cysteine and cysteine-containing peptides in vitro. Chem Pharm Bull (Tokyo) (1996) 0.79
Inactivation-reactivation of two-electron reduced Escherichia coli glutathione reductase involving a dimer-monomer equilibrium. Biochemistry (1989) 0.79
Acid- and pressure-induced (un)folding of yeast glutathione reductase: competition between protein oligomerization and aggregation. Int J Biochem Cell Biol (2005) 0.78
Preparation and biological activity of amino acid and peptide conjugates of antitumor hydroxymethylacylfulvene. J Med Chem (2000) 0.77
Irofulven, a novel inhibitor of DNA synthesis, in metastatic renal cell cancer. Invest New Drugs (2002) 0.77
Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. Eur J Biochem (1988) 0.77
Human erythrocyte glutathione reductase: chemical mechanism and structure of the transition state for hydride transfer. Biochemistry (1991) 0.76
Metabolism by rat liver cytosol of illudin S, a toxic substance of Lampteromyces japonicus. II. Characterization of illudin S-metabolizing enzyme. Xenobiotica (1992) 0.76
Isocyanate binding to yeast glutathione reductase measured by fluorescence spectroscopy. Biochem Soc Trans (1997) 0.76
Inactivation of yeast glutathione reductase by O-phthalaldehyde. J Enzyme Inhib (1996) 0.76
Unfolding kinetics of glutathione reductase from cyanobacterium Spirulina maxima. Arch Biochem Biophys (2001) 0.76
Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. Chem Res Toxicol (2003) 1.40
Quantitation of pyridyloxobutyl DNA adducts of tobacco-specific nitrosamines in rat tissue DNA by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem Res Toxicol (2006) 1.30
Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. Chem Res Toxicol (2004) 1.24
Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide induced NFkappaB and AP-1 activity. Carcinogenesis (2006) 1.10
Reactions of formaldehyde plus acetaldehyde with deoxyguanosine and DNA: formation of cyclic deoxyguanosine adducts and formaldehyde cross-links. Chem Res Toxicol (2003) 1.03
Identification of adducts produced by the reaction of 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol with deoxyguanosine and DNA. Chem Res Toxicol (2003) 0.96
Investigating the biochemical impact of DNA damage with structure-based probes: abasic sites, photodimers, alkylation adducts, and oxidative lesions. Biochemistry (2009) 0.93
Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent. J Am Chem Soc (2007) 0.92
Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents. Chem Rev (2012) 0.91
Quantitative correlation of drug bioactivation and deoxyadenosine alkylation by acylfulvene. Chem Res Toxicol (2007) 0.90
Investigating the role of stereochemistry in the activity of anticancer acylfulvenes: synthesis, reductase-mediated bioactivation, and cellular toxicity. J Med Chem (2006) 0.90
Influence of C-5 substituted cytosine and related nucleoside analogs on the formation of benzo[a]pyrene diol epoxide-dG adducts at CG base pairs of DNA. Nucleic Acids Res (2011) 0.89
A synthetic nucleoside probe that discerns a DNA adduct from unmodified DNA. J Am Chem Soc (2007) 0.86
Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent. J Pharmacol Exp Ther (2012) 0.84
Specific incorporation of an artificial nucleotide opposite a mutagenic DNA adduct by a DNA polymerase. J Am Chem Soc (2014) 0.83
Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediates. Chem Res Toxicol (2011) 0.82
Nucleobase-dependent reactivity of a quinone metabolite of pentachlorophenol. Chem Res Toxicol (2007) 0.81
O6-alkylguanine postlesion DNA synthesis is correct with the right complement of hydrogen bonding. ACS Chem Biol (2014) 0.80
Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes. Chem Res Toxicol (2011) 0.80
Induction of complementary function reductase enzymes in colon cancer cells by dithiole-3-thione versus sodium selenite. J Biochem Mol Toxicol (2014) 0.80
Quantification of acylfulvene- and illudin S-DNA adducts in cells with variable bioactivation capacities. Chem Res Toxicol (2012) 0.79
Deoxygenated phosphorothioate inositol phosphate analogs: synthesis, phosphatase stability, and binding affinity. Bioorg Med Chem (2007) 0.79
Transcriptomic responses of cancerous and noncancerous human colon cells to sulforaphane and selenium. Chem Res Toxicol (2014) 0.79
Simultaneous determination of inositol and inositol phosphates in complex biological matrices: quantitative ion-exchange chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2009) 0.78
Reversible aggregation of DNA-decorated gold nanoparticles controlled by molecular recognition. Langmuir (2013) 0.77
Bioreduction-mediated food-drug interactions: opportunities for oncology nutrition. Chimia (Aarau) (2011) 0.77
Torsional Constraints of DNA Substrates Impact Cas9 Cleavage. J Am Chem Soc (2016) 0.77
Systems toxicology approach to understand the kinetics of benzo(a)pyrene uptake, biotransformation, and DNA adduct formation in a liver cell model. Chem Res Toxicol (2014) 0.77
Hydrogen bonding or stacking interactions in differentiating duplex stability in oligonucleotides containing synthetic nucleoside probes for alkylated DNA. Chemistry (2013) 0.77
Fluorescent THF-based fructose analogue exhibits fructose-dependent uptake. Chembiochem (2013) 0.77
Characterization of a deoxyguanosine adduct of tetrachlorobenzoquinone: dichlorobenzoquinone-1,N2-etheno-2'-deoxyguanosine. Chem Res Toxicol (2005) 0.77
Incorporation of nucleoside probes opposite O⁶-methylguanine by Sulfolobus solfataricus DNA polymerase Dpo4: importance of hydrogen bonding. Chembiochem (2013) 0.76
Tolerance of base pair size and shape in postlesion DNA synthesis. J Am Chem Soc (2013) 0.76
Recognition of O6-benzyl-2'-deoxyguanosine by a perimidinone-derived synthetic nucleoside: a DNA interstrand stacking interaction. Nucleic Acids Res (2013) 0.76
Improved efficacy of acylfulvene in colon cancer cells when combined with a nuclear excision repair inhibitor. Chem Res Toxicol (2013) 0.76
Gold nanoprobes for detecting DNA adducts. Chem Commun (Camb) (2014) 0.76
Synthesis of deoxytetrahydrouridine. J Org Chem (2009) 0.75
Oligonucleotide probes containing pyrimidine analogs reveal diminished hydrogen bonding capacity of the DNA adduct O⁶-methyl-G in DNA duplexes. Bioorg Med Chem (2013) 0.75
Sulfotransferase-independent genotoxicity of illudin S and its acylfulvene derivatives in bacterial and mammalian cells. Arch Toxicol (2013) 0.75
Synthesis of oxygen-linked 8-phenoxyl-deoxyguanosine nucleoside analogues. European J Org Chem (2011) 0.75
Influence of chlorine substitution on the hydrolytic stability of biaryl ether nucleoside adducts produced by phenolic toxins. J Org Chem (2013) 0.75
Conformational Preference and Fluorescence Response of a C-Linked C8-Biphenyl-Guanine Lesion in the NarI Mutational Hotspot: Evidence for Enhanced Syn Adduct Formation. Chem Res Toxicol (2017) 0.75